CompletedNot Applicable

A Silver Lining in the VAD Sky

United States25 participantsStarted 2022-02-01

Plain-language summary

The investigators propose to conduct a prospective randomized trail (RCT) of a driveline management protocol. The study will be initiated at UCSF from January 1st 2022 to December 31st 2022 as a pilot to be extended to other sites with the ultimate goal to develop a multi-center RCT. The driveline dressing protocol studied will include a silver-based dressing barrier as well as a dressing change protocol and material designed to reduce the risk of driveline dressing induced dermatitis and allergies. Assessment will include DLI rates, DLI speciation, dermatitis rate, comfort, ease of use, compliance and cost

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \>18 years of age * Implanted with LVAD as DT or BTT at the Academic Medical Center with implantation scheduled between January 1st, 2022 and December 31st, 2022 Exclusion Criteria: * A history of DLI * A history of sternal wound infection * Implantation secondary to VAD exchange for device infection

What they're measuring

Driveline Infection Rate

Timeframe: 2 year

Trial details

NCT IDNCT05163392

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-01

Results submitted2024-12-26

View on ClinicalTrials.gov More LVAD (Left Ventricular Assist Device) Driveline Infection trials